TABLE 3.
Community | Term | FDR | Count | % | Fold enrichment |
---|---|---|---|---|---|
Community 1 | Regulation of transcription, DNA-templated | 3.31E-48 | 742 | 27.6 | 1.61 |
Keratinization | 1.13E-05 | 23 | 0.9 | 3.61 | |
Cell fate commitment | 4.27E-03 | 55 | 2.0 | 1.77 | |
Embryo development | 1.26E-02 | 162 | 6.0 | 1.33 | |
Community 5 | Intracellular signal transduction | 5.35E-75 | 740 | 26.2 | 1.85 |
Phosphorylation | 2.27E-69 | 642 | 22.7 | 1.91 | |
Cell cycle | 1.41E-42 | 463 | 16.4 | 1.84 | |
Cell projection organization | 5.20E-39 | 378 | 13.4 | 1.93 | |
Cell migration | 3.97E-26 | 319 | 11.3 | 1.79 | |
Cilium organization | 7.05E-17 | 89 | 3.2 | 2.60 | |
Community 15 | Transmembrane transport | 1.80E-74 | 503 | 15.0 | 2.19 |
Ion transport | 5.09E-72 | 532 | 15.9 | 2.10 | |
Chemical homeostasis | 6.68E-35 | 348 | 10.4 | 1.91 | |
Lipid metabolic process | 1.48E-27 | 392 | 11.7 | 1.70 | |
Inorganic ion transmembrane transport | 2.55E-27 | 250 | 7.5 | 1.99 | |
Sphingolipid biosynthetic process | 5.63E-16 | 56 | 1.7 | 3.29 | |
Protein exit from endoplasmic reticulum | 6.42E-10 | 28 | 0.8 | 3.93 | |
GPCR signaling pathway, coupled to cyclic nucleotide second messenger | 2.31E-07 | 68 | 2.0 | 2.03 | |
Cyclic purine nucleotide metabolic process | 1.46E-06 | 54 | 1.6 | 2.13 |